Brain Cancer Patients Gain First Approved PET Drug for Separating Tumor Regrowth From Treatment Related Change
The FDA has approved Pixclara, the first PET imaging drug for glioma, to help separate tumor regrowth from treatment-related change.
Medical Daily ·